Evaluation and treatment strategies in patients at high risk of sudden death post myocardial infarction.
Lewis
W R
WR
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D003645:Death, Sudden / Q000209:etiology*; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications*; D017180:Tachycardia, Ventricular / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents